Revolutionising Cancer Treatment with AI & Nanotechnology
At Prosemble, we are transforming cancer care with cutting-edge nanoparticle and AI technologies enhancing treatment efficacy while minimising side effects.
Cancer Cases every year
Chemotherapy Patients
Oncology market size in 2030
Pioneering Advancements
Our protein-based nanoparticle delivery system permits disease-specific targeting mechanisms, versatile drug loading for therapeutics, and atomic-level structural precision, offering enhanced engineering for superior cancer treatment.
Side effects experienced by patients...
%
Fatigue
%
Peripheral Neuropathy
%
Hair Loss
%
Liver Damage
%
Mucositis
%
Kidney Damage
%
of patients going through chemo experience significant side effects
%
fewer drugs required with Prosemble technology
%
of medicine currently gets to the tumours
Through Our Science We Are Transforming Cancer Treatment for Chemotherapy Patients
Latest News
Immunogenicity Results Received
Prosemble has received results from ongoing test of its protein nanoparticles in CD34+ humanised NCG mice. The results indicate excellent immunogenicity, with no B-cell activation, minimal cytokine production, and T-cell activation only due to natural ageing. Next...
Inna Zhuranskaya Joins Women-Led Global Business Programme in Health-Tech in Chennai
On 22 January 2026, Inna Zhuranskaya participated in the Women-Led Global Business Programme in Health-Tech, organized by the Biotechnology Industry Research Assistance Council (BIRAC) in collaboration with UKRI India and Innovate UK. The delegation’s visit to Chennai...
Inna Zhuranskaya Participates in UKRI & Innovate UK Women in Innovation Health-Tech Programme in Bengaluru
On 21 January 2026, Inna Zhuranskaya participated in the UK Research and Innovation (UKRI) & Innovate UK Global Business Innovation Programme (GBIP) – Women in Innovation Health-Tech, hosted in Bengaluru. The delegation, featuring 12 women-led companies from the...